Back to Search Start Over

Regulation of aortic extracellular matrix synthesis via noradrenergic system and angiotensin II in juvenile rats.

Authors :
Dab H
Hachani R
Dhaouadi N
Sakly M
Hodroj W
Randon J
Bricca G
Kacem K
Source :
Pharmaceutical biology [Pharm Biol] 2012 Oct; Vol. 50 (10), pp. 1219-25. Date of Electronic Publication: 2012 Aug 02.
Publication Year :
2012

Abstract

Context: Extracellular matrix (ECM) synthesis regulation by sympathetic nervous system (SNS) or angiotensin II (ANG II) was widely reported, but interaction between the two systems on ECM synthesis needs further investigation.<br />Objective: We tested implication of SNS and ANG II on ECM synthesis in juvenile rat aorta.<br />Materials and Methods: Sympathectomy with guanethidine (50 mg/kg, subcutaneous) and blockade of the ANG II AT1 receptors (AT1R) blocker with losartan (20 mg/kg/day in drinking water) were performed alone or in combination in rats. mRNA and protein synthesis of collagen and elastin were examined by Q-RT-PCR and immunoblotting.<br />Results: Collagen type I and III mRNA were increased respectively by 62 and 43% after sympathectomy and decreased respectively by 31 and 60% after AT1R blockade. Combined treatment increased collagen type III by 36% but not collagen type I. The same tendency of collagen expression was observed at mRNA and protein levels after the three treatments. mRNA and protein level of elastin was decreased respectively by 63 and 39% and increased by 158 and 15% after losartan treatment. Combined treatment abrogates changes induced by single treatments.<br />Discussion and Conclusion: The two systems act as antagonists on ECM expression in the aorta and combined inhibition of the two systems prevents imbalance of mRNA and protein level of collagen I and elastin induced by single treatment. Combined inhibition of the two systems prevents deposit or excessive reduction of ECM and can more prevent cardiovascular disorders.

Details

Language :
English
ISSN :
1744-5116
Volume :
50
Issue :
10
Database :
MEDLINE
Journal :
Pharmaceutical biology
Publication Type :
Academic Journal
Accession number :
22853187
Full Text :
https://doi.org/10.3109/13880209.2012.664554